Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
ERG-deficient endothelium identifies IL-8/CXCR2 axis as a therapeutic target for resolving neutrophilic lung vascular injury
Vigneshwaran Vellingiri, Vijay Avin Balaji Ragunathrao, Jagdish Chandra Joshi, Md Zahid Akhter, Mumtaz Anwar, Somenath Banerjee, Sayanti Datta, Viktor Pinneker, Steven Dudek, Yoshikazu Tsukasaki, Sandra Pinho, Dolly Mehta
Vigneshwaran Vellingiri, Vijay Avin Balaji Ragunathrao, Jagdish Chandra Joshi, Md Zahid Akhter, Mumtaz Anwar, Somenath Banerjee, Sayanti Datta, Viktor Pinneker, Steven Dudek, Yoshikazu Tsukasaki, Sandra Pinho, Dolly Mehta
View: Text | PDF
Research Article Inflammation Pulmonology Vascular biology

ERG-deficient endothelium identifies IL-8/CXCR2 axis as a therapeutic target for resolving neutrophilic lung vascular injury

  • Text
  • PDF
Abstract

Aberrant polymorphonuclear neutrophil (PMN) accumulation in tissues induces chronic vascular diseases. Endothelial cells (ECs) regulate the access of PMNs into the tissue from the blood. However, the mechanisms that prevent PMNs from being activated and accumulating in the tissue, a hallmark of acute lung injury (ALI), remain elusive. We demonstrate that conditional deletion of Erg in ECs spontaneously alters the PMN transcriptome, which is enriched with genes that induce PMN recruitment, adhesion, activation, and “do not eat me” signals due to impaired synthesis of the deubiquitinase A20. Decreased A20 levels, in turn, activated the transcription factor NF-κB and the secretion of MIP2α (human homolog of IL-8) in ECs. EC-secreted MIP2α/IL-8 engaged the CXCR2 cascade on PMNs, leading to their activation and inflammatory injury. These findings were recapitulated in the lungs and blood of PMNs from patients dying of ALI. Overexpression of the A20 gene in ECs or pharmacological inhibition of CXCR2 on PMNs in iEC-Erg–/– mice rescued EC control of PMNs and tissue homeostasis, and enhanced mouse survival after pneumonia. Thus, the EC/Erg/A20 axis regulates PMN accumulation and hyperactivation in the lungs by inhibiting EC-mediated IL-8 activation of PMN CXCR2, thereby providing a potential target for neutrophilic inflammatory vascular diseases.

Authors

Vigneshwaran Vellingiri, Vijay Avin Balaji Ragunathrao, Jagdish Chandra Joshi, Md Zahid Akhter, Mumtaz Anwar, Somenath Banerjee, Sayanti Datta, Viktor Pinneker, Steven Dudek, Yoshikazu Tsukasaki, Sandra Pinho, Dolly Mehta

×

Figure 1

EC Erg loss induces PMN infiltration and activation.

Options: View larger image (or click on image) Download as PowerPoint
EC Erg loss induces PMN infiltration and activation.
(A) Schematics of t...
(A) Schematics of tamoxifen injection and drug washout as described in the Methods in 5-week-old mice. (B and C) mRNA levels of indicated genes in ECs sorted from the lungs (B) and ERG protein (C) of indicated mice (n = 6). Gapdh was used as an internal control in B, while actin was used as a loading control for protein in C. Numbers indicate densitometric analysis. (D) Lung histopathology and inflammatory score of Ergfl/fl and iEC-Erg–/– lungs (n = 6). Scale bar: 20 μm. (E and F) Flow cytometric analysis of PMNs in the indicated lungs. (E) Representative FACS plot. (F) PMN percentage (n = 8) and absolute count (n = 3). (G and H) H&E-stained BAL from indicated mice (n = 6). (G) Representative images. (H) Quantification of PMNs per field of view (FOV). Scale bar: 100 μm. (I–K) Schematics (I) and intravital 2-photon analysis of PMNs (green) and ECs (red) in the indicated lungs following i.v. injection of BV421-labeled anti-Ly6G antibodies (for PMNs) (J and K). Red ECs were confirmed using SeTau647-labeled anti-CD31 antibodies (not shown). The lungs were imaged 30 minutes after the administration of the antibody. Scale bar: 50 μm. (J) Representative images. (K) PMN cell number and aspect ratio (FOV = 298 × 298 mm) (n = 6). Experiments were performed twice independently. (L and M) MPO immunostaining of Ergfl/fl and iEC-Erg–/– lungs (n = 3). The plot shows MPO+ cells, which represent mean MPO fluorescence intensity/region of interest, pooled together from 3 lungs/group performed independently. (L) Representative images (MPO, red; nuclei, blue [DAPI]) and quantitation of MPO+ cells. Scale bar: 10 μm. (M) MPO activity of Ergfl/fl and iEC-Erg–/– lung tissues. Data represented as mean ± SD. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001 by unpaired, 2-tailed Student’s t test (all plots). NS, not significant.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts